115 related articles for article (PubMed ID: 8067715)
1. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
Anticancer Res; 1994; 14(3B):1413-5. PubMed ID: 8067715
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
3. Single-agent vinorelbine in the treatment of non-small cell lung cancer.
Wozniak AJ
Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010
[TBL] [Abstract][Full Text] [Related]
4. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
5. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
6. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
[TBL] [Abstract][Full Text] [Related]
7. Update: vinorelbine (navelbine) in non-small cell lung cancer.
Crawford J
Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
[TBL] [Abstract][Full Text] [Related]
8. Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer.
Berrieman HK; Cawkwell L; O'Kane SL; Smith L; Lind MJ
Oncol Rep; 2006 Jan; 15(1):283-6. PubMed ID: 16328069
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
[TBL] [Abstract][Full Text] [Related]
10. Non small cell lung cancer treatment with vinorelbine monochemotherapy: a phase II study.
Clerici M; Bretti S; Celano A; Panvini D; Comandone A; Casadio C; Luporini G; Bumma C
Anticancer Res; 1995; 15(2):477-8. PubMed ID: 7763025
[TBL] [Abstract][Full Text] [Related]
11. A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.
Clarke SJ; Boyer MJ; Millward M; Underhill C; Moylan E; Yip D; White S; Childs A; Beale P; Latz J; Suri A; Iglesias JL
Lung Cancer; 2005 Sep; 49(3):401-12. PubMed ID: 15923057
[TBL] [Abstract][Full Text] [Related]
12. Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: phase II trial.
Buffoni L; Dongiovanni D; Barone C; Fissore C; Ottaviani D; Dongiovanni V; Grillo R; Salvadori A; Birocco N; Schena M; Bertetto O
Lung Cancer; 2006 Dec; 54(3):353-7. PubMed ID: 17049672
[TBL] [Abstract][Full Text] [Related]
13. Vinorelbine tartrate (Navelbine): drug profile and nursing implications of a new vinca alkaloid.
Brogden JM; Nevidjon B
Oncol Nurs Forum; 1995 May; 22(4):635-46. PubMed ID: 7675666
[TBL] [Abstract][Full Text] [Related]
14. Vinorelbine for treatment of advanced non-small-cell lung cancer.
Med Lett Drugs Ther; 1995 Aug; 37(955):72-3. PubMed ID: 7630328
[No Abstract] [Full Text] [Related]
15. A summary of vinorelbine (Navelbine) safety data from North American clinical trials.
Hohneker JA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):42-6; discussion 46-7. PubMed ID: 7973769
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).
Depierre A; Lemarie E; Dabouis G; Garnier G; Jacoulet P; Dalphin JC
Semin Oncol; 1989 Apr; 16(2 Suppl 4):26-9. PubMed ID: 2540532
[No Abstract] [Full Text] [Related]
17. Is class III beta-tubulin a true predictive marker of sensitivity to vinorelbine in non-small cell lung cancer? Chemosensitivity data evidence.
Hirai Y; Yoshimasu T; Oura S; Ota F; Naito K; Nishiguchi H; Hashimoto S; Okamura Y
Anticancer Res; 2011 Mar; 31(3):999-1005. PubMed ID: 21498728
[TBL] [Abstract][Full Text] [Related]
18. Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: a case series and review of the literature.
June RR; Dougherty DW; Reese CT; Harpster LE; Hoffman SL; Drabick JJ
Urol Oncol; 2012; 30(2):192-5. PubMed ID: 20363163
[TBL] [Abstract][Full Text] [Related]
19. Vinorelbine treatment IND program announced.
Am J Hosp Pharm; 1994 Sep; 51(17):2087. PubMed ID: 7755700
[No Abstract] [Full Text] [Related]
20. [Navelbine (vinorelbine): new antitumoral agent. Biarritz, November 2-3, 1989].
Lhommé C
Rev Prat; 1990 Sep; 40(19):1780-1. PubMed ID: 2171131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
